284 related articles for article (PubMed ID: 11728253)
1. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Heart Dis; 2000; 2(2):151-67. PubMed ID: 11728253
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
4. [Cardiological drugs and the elderly].
Grand A
Ann Cardiol Angeiol (Paris); 1997; 46(7):461-8. PubMed ID: 9452781
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular drugs and the elderly population.
Lapinski ML
Heart Lung; 1982; 11(5):430-4. PubMed ID: 6921190
[No Abstract] [Full Text] [Related]
6. Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women.
Schwartz JB
Cardiol Rev; 2003; 11(5):275-98. PubMed ID: 12943605
[TBL] [Abstract][Full Text] [Related]
7. Magnesium and cardiovascular drugs: interactions and therapeutic role.
Crippa G; Sverzellati E; Giorgi-Pierfranceschi M; Carrara GC
Ann Ital Med Int; 1999; 14(1):40-5. PubMed ID: 10528423
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of cardiovascular drugs in the elderly].
Imbs JL; Welsch M; Lates S
Bull Acad Natl Med; 2006; 190(4-5):843-53; discussion 853, 873-6. PubMed ID: 17195611
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacologic and therapeutic peculiarities in the aged, especially in the cardiovascular diseases].
Klaus W
Z Kardiol; 1985; 74 Suppl 7():27-31. PubMed ID: 2868583
[TBL] [Abstract][Full Text] [Related]
10. Therapy insight: how changes in renal function with increasing age affect cardiovascular drug prescribing.
Wyatt CM; Kim MC; Winston JA
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):102-9. PubMed ID: 16446779
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic basis for altered drug action in the elderly.
Roberts J; Tumer N
Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786
[TBL] [Abstract][Full Text] [Related]
12. Avoiding psychotropic drug interactions in the cardiovascular patient.
DeVane CL; Markowitz JS
Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular drugs and the older adult.
Potempa K; Roberts KV
Nurs Clin North Am; 1982 Jun; 17(2):263-74. PubMed ID: 6919936
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular drugs poisoning in the elderly patients hospitalized in the Province Poisoning Center in Lublin in the years 1995-2001].
Lewandowska-Stanek H; Gołacka E; Niewiedzioł M
Przegl Lek; 2002; 59(4-5):336-8. PubMed ID: 12184001
[TBL] [Abstract][Full Text] [Related]
15. [An analysis of pharmacotherapy in an internal medicine ambulatory care clinic, using the example of cardiovascular-effective drugs].
Conen D; Zschokke U; Dubach UC
Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1163-8. PubMed ID: 7280625
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular pharmacology of aging.
Podrazik PM; Schwartz JB
Cardiol Clin; 1999 Feb; 17(1):17-34. PubMed ID: 10093763
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. A population-based study on well-being in the very old: the role of cardiovascular diseases and drugs.
Westerbotn M; Agüero-Torres H; Fastbom J; Hillerås P
Arch Gerontol Geriatr; 2005; 40(3):287-97. PubMed ID: 15814162
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions in patients with cardiovascular disease.
Faulx MD; Francis GS
Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction.
Izzo AA; Di Carlo G; Borrelli F; Ernst E
Int J Cardiol; 2005 Jan; 98(1):1-14. PubMed ID: 15676159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
